We also examined whether blocking microglial glutamate release improved cognitive dysfunction in an AD mouse model using transgenic mice expressing mutant variants of human amyloid precursor protein (APP) and presenilin 1 (PS1) (APP/PS1 Tg mice). The gene discussed is PSEN1; the disease is Alzheimer disease.